In a head-to-head open-label trial reported in February 2026, average weight loss at 84 weeks favored tirzepatide, and the sponsor noted CagriSema did not meet its prespecified non-inferiority target against tirzepatide
Below, we break down how this stack works, who its for, and what results people are seeing based on real clinical insights from our medical team
Like other GLP-1 receptor agonists (GLP-1 RAs), semaglutide, administered once-weekly, stimulates insulin and suppresses glucagon secretion in a glucose-dependent manner
No matter the cause, scientists stress that dehydration necessitates special attention as it may contribute to renal failure (in less than half a percent of users) and other kidney issues
Related products Serums Original price was: 36,25 .Current price is: 19,69